Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86,937 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, Ding WB, Li WH, Huang JH, Mu W, Gu SZ, Li JP, Zhao H, Wen SW, Lei YM, Song YS, Yuan CW, Wang WD, Huang M, Zhao W, Wu JB, Wang S, Zhu X, Han JJ, Ren WX, Lu ZM, Xing WG, Fan Y, Lin HL, Zhang ZS, Xu GH, Hu WH, Tu Q, Su HY, Zheng CS, Chen Y, Zhao XY, Fang ZT, Wang Q, Zhao JW, Xu AB, Xu J, Wu QH, Niu HZ, Wang J, Dai F, Feng DP, Li QD, Shi RS, Li JR, Yang G, Shi HB, Ji JS, Liu YE, Cai Z, Yang P, Zhao Y, Zhu XL, Lu LG, Teng GJ; CHANCE001 Investigators. Zhu HD, et al. Among authors: zhao h, zhao y, zhao w, zhao jw, zhao xy. Signal Transduct Target Ther. 2023 Feb 8;8(1):58. doi: 10.1038/s41392-022-01235-0. Signal Transduct Target Ther. 2023. PMID: 36750721 Free PMC article.
Irradiation stent with 125 I plus TACE versus sorafenib plus TACE for hepatocellular carcinoma with major portal vein tumor thrombosis: a multicenter randomized trial.
Lu J, Guo JH, Ji JS, Li YL, Lv WF, Zhu HD, Sun JH, Ren WX, Zhang FJ, Wang WD, Shao HB, Cao GS, Li HL, Gao K, Yang P, Yin GW, Zhu GY, Wu FZ, Wang WJ, Lu D, Chen SQ, Min J, Zhao Y, Li R, Lu LG, Lau WY, Teng GJ. Lu J, et al. Among authors: zhao y. Int J Surg. 2023 May 1;109(5):1188-1198. doi: 10.1097/JS9.0000000000000295. Int J Surg. 2023. PMID: 37038986 Free PMC article. Clinical Trial.
Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APL.
Zhou X, Chen X, Chen J, Wen L, Zhang Z, Qin YZ, Cao P, Xing H, Mi Y, Wang W, Zhang G, Li J, Wu H, Zhang Z, Zhang J, Su Z, Wang F, Zhang Y, Ma X, Fang J, Wu P, Wang T, Fan G, Zhao Y, Jin D, Zhang X, Ma X, Wu Q, Zhang Z, Wang L, Ma F, Xiao X, Wu C, Sun K, Tang R, Zhang Y, Wu S, Gao R, Zhang L, Zheng H, Zhao Y, Zhu HH, Lu D, Lu P, Chen S, Liu H. Zhou X, et al. Among authors: zhao y. Blood. 2024 Oct 3;144(14):1471-1485. doi: 10.1182/blood.2024023883. Blood. 2024. PMID: 39046762
Comparison of Inferior Extensor Retinacular Reinforcement Versus Nonreinforcement in Arthroscopic Isolated Anterior Talofibular Ligament Repair for Chronic Lateral Ankle Instability: A Systematic Review and Meta-analysis.
Shan L, Zhao B, Wang H, Zhao Y, Diao S, Xu X, Gao Y, Sun Q, Lu T, Zhou J, Liu Y. Shan L, et al. Among authors: zhao y. Orthop J Sports Med. 2024 Dec 20;12(12):23259671241270305. doi: 10.1177/23259671241270305. eCollection 2024 Dec. Orthop J Sports Med. 2024. PMID: 39711611 Free PMC article.
86,937 results
You have reached the last available page of results. Please see the User Guide for more information.